Composition and method for treating hemorrhoids and/or anorectal disorders
AssigneeWyeth
InventorsGary Robert Agisim, Richard John Kenny, Miron Gerard Still, Ellen Bland Gilliam, Helen Elizabeth Taylor
Life of this patent
Estimating the term…
Abstract
The invention provides an oil-in-water emulsion useful in the treatment of anorectal disorders comprising a local anesthetic, vasoconstrictor, glycerin and water, and method of preparation of the emulsion and a method for treating hemorrhoids using the composition of the invention.
Claims2
A pharmaceutical composition consisting of 1.00% w/w pramoxine hydrochloride, 0.250% w/w phenylephrine hydrochloride, 15.0% w/w white petrolatum, 14.4% w/w glycerin, 1.00% w/w steareth-20, 1.00% w/w steareth-2, 3.00% w/w glyceryl monostearate and laureth-23 70/30, 5.00% w/w stearyl alcohol, 5.00% w/w cetyl alcohol, 0.200% w/w methylparaben, 0.100% w/w propylparaben, 0.200% w/w sodium benzoate, 0.0500% w/w disodium edetate, 0.500% w/w mixed tocopherols, 0.200% w/w propyl gallate and BHA in propylene glycol, 0.250% w/w sodium carboxymethylcellulose, 0.100% w/w xanthan, 0.200% w/w citric acid, 0.100% w/w aloe vera oil, 0.100% w/w vitamin E acetate, 1.00% w/w D-panthenol, and 51.35% w/w water;
- wherein the pharmaceutical composition is an oil-in-water emulsion and the oil-in-water emulsion is a cream, wherein the pramoxine hydrochloride and phenylephrine hydrochloride are solubilized in the water portion of the oil-in-water emulsion, wherein the at least one non-ionic emulsifier includes an ethoxylated fatty alcohol that is a solid at room temperature, wherein the ratio of the glycerin amount by weight to the sum of the glycerin amount and water by weight is about 20% to about 45%, wherein the pH range of the composition is about 3.5 to about 4.2, and wherein the composition provides hydration to hemorrhoid and/or anorectal tissue.
A method of treating hemorrhoids and/or anorectal disorders in humans comprising administering to the anorectal region a safe and effective amount of a pharmaceutical composition, the pharmaceutical composition consisting of 1.00% w/w pramoxine hydrochloride, 0.250% w/w phenylephrine hydrochloride, 15.0% w/w white petrolatum, 14.4% w/w glycerin, 1.00% w/w steareth-20, 1.00% w/w steareth-2, 3.00% w/w glyceryl monostearate and laureth-23 70/30, 5.00% w/w stearyl alcohol, 5.00% w/w cetyl alcohol, 0.200% w/w methylparaben, 0.100% w/w propylparaben, 0.200% w/w sodium benzoate, 0.0500% w/w disodium edetate, 0.500% w/w mixed tocopherols, 0.200% w/w propyl gallate and BHA in propylene glycol, 0.250% w/w sodium carboxymethylcellulose, 0.100% w/w xanthan, 0.200% w/w citric acid, 0.100% w/w aloe vera oil, 0.100% w/w vitamin E acetate, 1.00% w/w D-panthenol, and 51.35% w/w water;
- wherein the pharmaceutical composition is an oil-in-water emulsion and the oil-in-water emulsion is a cream, wherein the pramoxine hydrochloride and phenylephrine hydrochloride are solubilized in the water portion of the oil-in-water emulsion, wherein the at least one non-ionic emulsifier includes an ethoxylated fatty alcohol that is a solid at room temperature, wherein the ratio of the glycerin amount by weight to the sum of the glycerin amount and water by weight is about 20% to about 45%, wherein the pH range of the composition is about 3.5 to about 4.2, and wherein the composition provides hydration to hemorrhoid and/or anorectal tissue.
Dependencies are inferred from the claim text.